For years, researchers have suspected that a hormone called relaxin could be an effective treatment for certain cardiovascular diseases. It helps counteract scarring (fibrosis), prevents veins and ...

What you need to know The prevalence of heart failure across Europe is estimated to be 1-2% of adults.1 In the UK, this places a substantial burden on patients and healthcare resources, including ...

After a heart attack, the heart struggles to recoup and maintain energy. One third of patients develop heart failure as a ...

After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a result—a condition that impacts 6.8 million Americans and carries a high ...

MRI results highlighted that patients with baseline cardiomyopathy saw a 3.3 percentage-point improvement in left ventricular ejection fraction. ・Capricor has already submitted a BLA for Deramiocel to ...

You've probably heard or read about congestive heart failure. Maybe you've even been told you have it, or know someone who ...

Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...

Characterized by weakened or damaged heart musculature, heart failure results in the gradual buildup of fluid in a patient's lungs, legs, feet, and other parts of the body. The condition is chronic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Beta-blockers did not improve clinical outcomes after ...

A @HopkinsMedicine-led study offers strong evidence that adults with coexisting prediabetes and hypertension are at a higher ...

The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...